Lifevantage Shares Outstanding 2011-2025 | LFVN
Lifevantage shares outstanding from 2011 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
|
Lifevantage Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025 | 13 |
| 2024 | 13 |
| 2023 | 13 |
| 2022 | 13 |
| 2021 | 14 |
| 2020 | 15 |
| 2019 | 15 |
| 2018 | 14 |
| 2017 | 14 |
| 2016 | 15 |
| 2015 | 14 |
| 2014 | 16 |
| 2013 | 18 |
| 2012 | 17 |
| 2011 | 10 |
|
Lifevantage Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-06-30 | 13 |
| 2025-03-31 | 13 |
| 2024-12-31 | 13 |
| 2024-09-30 | 13 |
| 2024-06-30 | 13 |
| 2024-03-31 | 13 |
| 2023-12-31 | 13 |
| 2023-09-30 | 13 |
| 2023-06-30 | 13 |
| 2023-03-31 | 13 |
| 2022-12-31 | 13 |
| 2022-09-30 | 12 |
| 2022-06-30 | 13 |
| 2022-03-31 | 13 |
| 2021-12-31 | 13 |
| 2021-09-30 | 13 |
| 2021-06-30 | 14 |
| 2021-03-31 | 14 |
| 2020-12-31 | 14 |
| 2020-09-30 | 15 |
| 2020-06-30 | 15 |
| 2020-03-31 | 15 |
| 2019-12-31 | 15 |
| 2019-09-30 | 15 |
| 2019-06-30 | 15 |
| 2019-03-31 | 15 |
| 2018-12-31 | 15 |
| 2018-09-30 | 15 |
| 2018-06-30 | 14 |
| 2018-03-31 | 14 |
| 2017-12-31 | 14 |
| 2017-09-30 | 14 |
| 2017-06-30 | 14 |
| 2017-03-31 | 14 |
| 2016-12-31 | 14 |
| 2016-09-30 | 14 |
| 2016-06-30 | 15 |
| 2016-03-31 | 14 |
| 2015-12-31 | 14 |
| 2015-09-30 | 14 |
| 2015-06-30 | 14 |
| 2015-03-31 | 14 |
| 2014-12-31 | 14 |
| 2014-09-30 | 15 |
| 2014-06-30 | 16 |
| 2014-03-31 | 15 |
| 2013-12-31 | 16 |
| 2013-09-30 | 18 |
| 2013-06-30 | 18 |
| 2013-03-31 | 18 |
| 2012-12-31 | 18 |
| 2012-09-30 | 18 |
| 2012-06-30 | 17 |
| 2012-03-31 | 15 |
| 2011-12-31 | 17 |
| 2011-09-30 | 17 |
| 2011-06-30 | 12 |
| 2011-03-31 | 10 |
| 2010-12-31 | 13 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.094B | $0.229B |
| Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $105.158B | 23.49 |
| Becton Dickinson (BDX) | United States | $50.974B | 12.33 |
| Cardinal Health (CAH) | United States | $48.391B | 22.86 |
| West Pharmaceutical Services (WST) | United States | $19.500B | 38.34 |
| Straumann Holding AG (SAUHY) | Switzerland | $19.310B | 0.00 |
| Cooper (COO) | United States | $13.937B | 17.44 |
| Align Technology (ALGN) | United States | $9.675B | 18.27 |
| Henry Schein (HSIC) | United States | $8.464B | 14.92 |
| Merit Medical Systems (MMSI) | United States | $5.191B | 25.52 |
| DENTSPLY SIRONA (XRAY) | United States | $2.230B | 7.08 |
| CONMED (CNMD) | United States | $1.361B | 9.73 |
| STAAR Surgical (STAA) | United States | $1.321B | 0.00 |
| Pro-Dex (PDEX) | United States | $0.101B | 12.04 |